Alberto Fusi
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Ulrich KeilholzPaul LoriganAnika NonnenmacherCaroline DiveAntonia BusseIngeborg TinhoferSebastian OchsenreitherZhian Liu
- Topics
- Immunotherapy and Immune Responses (13 papers)Melanoma and MAPK Pathways (10 papers)Lung Cancer Treatments and Mutations (10 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- GermanyUnited KingdomItaly
In The Last Decade
Alberto Fusi
51 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Oncology 909
- Molecular Biology 599
- Cancer Research 491
- Immunology 362
- Pulmonary and Respiratory Medicine 251
Countries citing papers authored by Alberto Fusi
This map shows the geographic impact of Alberto Fusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Fusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Fusi more than expected).
Fields of papers citing papers by Alberto Fusi
This network shows the impact of papers produced by Alberto Fusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Fusi. The network helps show where Alberto Fusi may publish in the future.
Co-authorship network of co-authors of Alberto Fusi
This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Fusi. A scholar is included among the top collaborators of Alberto Fusi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Fusi. Alberto Fusi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 46 | |
| 5 | 40 | |
| 6 | 54 | |
| 7 | 282 | |
| 8 | 18 | |
| 9 | 5 | |
| 10 | 107 | |
| 11 | 53 | |
| 12 | 10 | |
| 13 | 15 | |
| 14 | 12 | |
| 15 | 26 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 2 | |
| 19 | 83 | |
| 20 | 31 |
About Alberto Fusi
Alberto Fusi is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Melanoma and MAPK Pathways (10 papers) and Lung Cancer Treatments and Mutations (10 papers). The work is most often cited by research in Oncology (909 citations), Cancer Research (491 citations) and Immunology (362 citations). Alberto Fusi has collaborated with scholars based in Germany, United Kingdom and Italy. Frequent co-authors include Ulrich Keilholz, Paul Lorigan, Anika Nonnenmacher, Caroline Dive, Antonia Busse, Ingeborg Tinhofer, Sebastian Ochsenreither, Zhian Liu, Alexander Schmittel and Fiona Blackhall. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.